Earnings Outlook For Relay Therapeutics
Portfolio Pulse from Benzinga Insights
Relay Therapeutics (NASDAQ:RLAY) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.81. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $11.25, down 43.64% over the last 52-week period.
August 07, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Relay Therapeutics is expected to report an EPS of $-0.81. The stock has been on a downward trend, down 43.64% over the last year.
The company's stock has been on a downward trend, which may continue if the earnings report is not positive. The estimated EPS is negative, which could further impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100